SCHEMBL7308381

SCHEMBL7308381

c1cc(-c2ccncc2)c2nccn2c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.50
DYRK1A Q13627 3/20 0.44
ADORA2A P29274 2/20 0.43
ALDH1A3 P47895 3/20 0.42
ALDH1A2 O94788 2/20 0.42
NUDT1 P36639 1/20 0.41
ADRA2A P08913 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
HDAC8 Q9BY41 1/20 0.38
KDR P35968 2/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
NOTUM Q6P988 1/20 0.37
AKT1 P31749 1/20 0.36
BACE1 P56817 1/20 0.36
PIK3CD O00329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4672079 0.89 ALDH1A3 (0.54) JAK2DYRK1AALDH1A3ALDH1A2NUDT1
SCHEMBL2900371 0.84 CCNE2 (0.47) JAK2DYRK1AALDH1A3ALDH1A2NUDT1
SCHEMBL1431759 0.84 TNKS (0.47) JAK2ALDH1A3ALDH1A2NUDT1KDR
SCHEMBL7311707 0.84 KDR (0.48) JAK2DYRK1AADORA2AALDH1A3ALDH1A2
SCHEMBL7317792 0.84 ALDH1A3 (0.54) JAK2ALDH1A3ALDH1A2NUDT1KDR
SCHEMBL12970128 0.81 MKNK1 (0.40) JAK2ALDH1A3ALDH1A2NUDT1HDAC8
SCHEMBL7311978 0.80 MEN1 (0.54) LMNAMAPTNOTUM
SCHEMBL13574557 0.79 FYN (0.38) ALDH1A3ALDH1A2NUDT1ADRA1DADRA1A
SCHEMBL7318740 0.79 ALDH1A1 (0.44) JAK2ALDH1A3ALDH1A2
SCHEMBL3315531 0.78 NUDT1 (0.42) ALDH1A3ALDH1A2NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240182467-A1 INHIBITORS OF RAF KINASES Pierre Fabre Médicament (FR) 2024-06-06 US disclosed
US-11814384-B2 Inhibtors of Raf kinases KINNATE BIOPHARMA INC. (US) 2023-11-14 US disclosed
US-4596872-A Imidazo[1,2-a]pyridines, and process for their preparation SCHERING A.G. (DE) 1986-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240182467-A1 INHIBITORS OF RAF KINASES BRAF, RAF1, ARAF JAK2 54/4885DYRK1A 534/4885ADORA2A 3874/4885
US-11814384-B2 Inhibtors of Raf kinases RAF1, BRAF, ARAF JAK2 229/4885DYRK1A 763/4885ADORA2A 3620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.